Activation-induced cytidine deaminase sustains glycolytic flux through MYST1 acetyltransferase-dependent lactylation in hepatocellular carcinoma.
A previously unrecognized AID-MYST1-lactylation-glycolysis axis that underpins the metabolic plasticity of HCC is delineated, offering a promising therapeutic strategy to target metabolic dependencies in liver cancer.